The effectiveness and cost-effectiveness of biomarkers for the prioritisation of patients awaiting coronary revascularisation: a systematic review and decision model

H Hemingway; M Henriksson; R Chen; J Damant; N Fitzpatrick; K Abrams; A Hingorani; M Janzon; M Shipley; G Feder; B Keogh; U Stenestrand; K McAllister; J-C Kaski; A Timmis; S Palmer; M Sculpher

doi:10.3310/hta14090

The effectiveness and cost-effectiveness of biomarkers for the prioritisation of patients awaiting coronary revascularisation: a systematic review and decision model

H Hemingway, M Henriksson, R Chen, J Damant, N Fitzpatrick, K Abrams, A Hingorani, M Janzon, M Shipley, G Feder, B Keogh, U Stenestrand, K McAllister, J-C Kaski, A Timmis, S Palmer, M Sculpher

Centre for Health Economics

Research output: Contribution to journal › Article › peer-review

Abstract

To determine the effectiveness and cost-effectiveness of a range of strategies based on conventional clinical information and novel circulating biomarkers for prioritising patients with stable angina awaiting coronary artery bypass grafting (CABG).

Original language	English
Pages (from-to)	1-178
Number of pages	178
Journal	Health technology assessment
Volume	14
Issue number	9
DOIs	https://doi.org/10.3310/hta14090
Publication status	Published - Feb 2010

Keywords

Age Factors
Biological Markers
Cardiovascular Diseases
Cost-Benefit Analysis
Decision Support Techniques
Great Britain
Health Care Rationing
Humans
Myocardial Revascularization
Prognosis
Risk Factors
State Medicine
Waiting Lists

Access to Document

10.3310/hta14090

http://www.hta.ac.uk/project/1515.asp

Cite this

Hemingway, H., Henriksson, M., Chen, R., Damant, J., Fitzpatrick, N., Abrams, K., Hingorani, A., Janzon, M., Shipley, M., Feder, G., Keogh, B., Stenestrand, U., McAllister, K., Kaski, J.-C., Timmis, A., Palmer, S., & Sculpher, M. (2010). The effectiveness and cost-effectiveness of biomarkers for the prioritisation of patients awaiting coronary revascularisation: a systematic review and decision model. Health technology assessment, 14(9), 1-178. https://doi.org/10.3310/hta14090

@article{b6b271ef889f47cda21b227b3b9cd61b,

title = "The effectiveness and cost-effectiveness of biomarkers for the prioritisation of patients awaiting coronary revascularisation: a systematic review and decision model",

abstract = "To determine the effectiveness and cost-effectiveness of a range of strategies based on conventional clinical information and novel circulating biomarkers for prioritising patients with stable angina awaiting coronary artery bypass grafting (CABG).",

keywords = "Age Factors, Biological Markers, Cardiovascular Diseases, Cost-Benefit Analysis, Decision Support Techniques, Great Britain, Health Care Rationing, Humans, Myocardial Revascularization, Prognosis, Risk Factors, State Medicine, Waiting Lists",

author = "H Hemingway and M Henriksson and R Chen and J Damant and N Fitzpatrick and K Abrams and A Hingorani and M Janzon and M Shipley and G Feder and B Keogh and U Stenestrand and K McAllister and J-C Kaski and A Timmis and S Palmer and M Sculpher",

year = "2010",

month = feb,

doi = "10.3310/hta14090",

language = "English",

volume = "14",

pages = "1--178",

journal = "Health technology assessment",

issn = "1366-5278",

publisher = "NHS National Institute for Health Research",

number = "9",

}

Hemingway, H, Henriksson, M, Chen, R, Damant, J, Fitzpatrick, N, Abrams, K, Hingorani, A, Janzon, M, Shipley, M, Feder, G, Keogh, B, Stenestrand, U, McAllister, K, Kaski, J-C, Timmis, A, Palmer, S & Sculpher, M 2010, 'The effectiveness and cost-effectiveness of biomarkers for the prioritisation of patients awaiting coronary revascularisation: a systematic review and decision model', Health technology assessment, vol. 14, no. 9, pp. 1-178. https://doi.org/10.3310/hta14090

TY - JOUR

T1 - The effectiveness and cost-effectiveness of biomarkers for the prioritisation of patients awaiting coronary revascularisation

T2 - a systematic review and decision model

AU - Hemingway, H

AU - Henriksson, M

AU - Chen, R

AU - Damant, J

AU - Fitzpatrick, N

AU - Abrams, K

AU - Hingorani, A

AU - Janzon, M

AU - Shipley, M

AU - Feder, G

AU - Keogh, B

AU - Stenestrand, U

AU - McAllister, K

AU - Kaski, J-C

AU - Timmis, A

AU - Palmer, S

AU - Sculpher, M

PY - 2010/2

Y1 - 2010/2

N2 - To determine the effectiveness and cost-effectiveness of a range of strategies based on conventional clinical information and novel circulating biomarkers for prioritising patients with stable angina awaiting coronary artery bypass grafting (CABG).

AB - To determine the effectiveness and cost-effectiveness of a range of strategies based on conventional clinical information and novel circulating biomarkers for prioritising patients with stable angina awaiting coronary artery bypass grafting (CABG).

KW - Age Factors

KW - Biological Markers

KW - Cardiovascular Diseases

KW - Cost-Benefit Analysis

KW - Decision Support Techniques

KW - Great Britain

KW - Health Care Rationing

KW - Humans

KW - Myocardial Revascularization

KW - Prognosis

KW - Risk Factors

KW - State Medicine

KW - Waiting Lists

UR - http://www.scopus.com/inward/record.url?scp=77952997264&partnerID=8YFLogxK

U2 - 10.3310/hta14090

DO - 10.3310/hta14090

M3 - Article

C2 - 20184812

SN - 1366-5278

VL - 14

SP - 1

EP - 178

JO - Health technology assessment

JF - Health technology assessment

IS - 9

ER -

The effectiveness and cost-effectiveness of biomarkers for the prioritisation of patients awaiting coronary revascularisation: a systematic review and decision model

Abstract

Keywords

Access to Document

Other files and links

Cite this